Hassan has a Ph.D. in Human Genetics. He used early cutting edge technologies of the human genome to identify the first genes causing hereditary hearing loss. During postdoctoral and junior faculty positions at the University Michigan, he pioneered microarray technologies in the prostate cancer field and the identification of genes involved in kidney disease. In 2011, he joined the Genetics Department at Stanford University, focusing on next generation sequencing technologies and stem cell therapy of muscular dystrophy. He led several projects between Stanford and the major sequencing companies Illumina and Complete Genomics. He is currently the Director of Lab Operations for SCGPM and the GSSC and Director of Stem Cell Genomics at the CIRM CESCG. Hassan is a co-author of 30 manuscripts.
